Article
Potential and limitations of IL-37, a cytokine targeted for therapy of systemic lupus erythematosus: A Systematic Review.
International immunopharmacology - 10 Jan 2025
Mohamed Thaha Ummul Aqeela Balqees, Wan Mohamad Wan Majdiah, Nik Husain Nik Rosmawati, Yusop Norhayati, Mohamud Rohimah, Wan Ghazali Wan Syamimee
Abstract excerpt
BACKGROUND: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by dysregulated immune responses and inflammation. Interleukin-37 (IL-37) is a recently discovered immunomodulatory cytokine with potential anti-inflammatory properties. This systematic review explores the relationship between IL and 37 and SLE disease activity, and evaluates its potential as a therapeutic agent. METHODS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
